HbA1c Test in Australia

What an HbA1c test is

HbA1c, or glycated haemoglobin, is the fraction of haemoglobin in your red cells that has glucose irreversibly attached to it, expressed in Australia as millimoles per mole of total haemoglobin.

Glucose in the bloodstream binds slowly and non-enzymatically to haemoglobin inside red cells. The higher the average glucose concentration and the longer the exposure, the greater the proportion of haemoglobin that ends up glycated. Because red cells live roughly 120 days, the measurement integrates glucose exposure over the preceding two to three months, weighted towards the most recent four to six weeks.

That averaging property is what makes HbA1c useful. A fasting glucose is a single instantaneous snapshot that moves with what you ate yesterday, how you slept and whether you are unwell. HbA1c cannot be gamed by fasting for a day, and it needs no preparation at all.

Australia reports HbA1c primarily in IFCC units (mmol/mol), with the older DCCT/NGSP percentage alongside, because both remain in circulation. The two are directly convertible: 42 mmol/mol equals 6.0%, 48 mmol/mol equals 6.5%, 53 mmol/mol equals 7.0%.

Since 2014, an HbA1c performed in an accredited Australian laboratory has been Medicare-rebatable for diagnosing diabetes in asymptomatic at-risk adults, and it is the test most Australian GPs now use for both diagnosis and monitoring.

Why HbA1c is measured

HbA1c is used to diagnose type 2 diabetes, to identify people at high risk before diabetes develops, and to monitor glycaemic control in people already diagnosed.

Type 2 diabetes develops silently. Australians commonly live with elevated glucose for years before symptoms appear, and by the time thirst, frequent urination or blurred vision are noticeable, damage to small blood vessels may already have begun. A single HbA1c identifies that state without symptoms and without fasting.

The intermediate zone matters just as much. An HbA1c of 42–47 mmol/mol (6.0–6.4%) is not diabetes, but it marks substantially raised risk of progressing to it — a group where structured lifestyle change through programs such as those offered by Diabetes Australia demonstrably reduces progression.

For people already diagnosed, HbA1c is the standard monitoring test, typically repeated every three to six months. Targets are individualised by a doctor: a general target around 53 mmol/mol (7.0%) is common, but appropriate targets differ with age, duration of diabetes, medicines used and hypoglycaemia risk.

• Family history of type 2 diabetes, or a personal history of gestational diabetes.
• Overweight or obesity, particularly central adiposity.
• High blood pressure, abnormal lipids or polycystic ovary syndrome.
• Aboriginal and Torres Strait Islander, Pacific Islander, South Asian, Chinese or Middle Eastern ancestry, where risk is higher at younger ages.
• Symptoms such as thirst, frequent urination, fatigue, recurrent infections or slow-healing wounds — see your GP promptly for these.

What a high result can indicate

A raised HbA1c indicates that average blood glucose has been elevated over recent months, and at 48 mmol/mol (6.5%) or above it meets the Australian laboratory threshold for diagnosing diabetes.

Diagnosis is not made on one number in isolation. Australian practice is that in an asymptomatic person a diagnostic HbA1c should be confirmed by a repeat test, and interpretation always sits with a doctor who can consider symptoms, other results and your history.

Results in the 42–47 mmol/mol (6.0–6.4%) band indicate high risk rather than disease. This is the range where GPs discuss diet, physical activity, weight and sleep, and where a structured Australian diabetes prevention program is often recommended.

Some elevations are artefactual. Iron deficiency anaemia can falsely raise HbA1c because older red cells persist longer. So can B12 deficiency, splenectomy and some haemoglobin variants, depending on the assay. This is a real reason to run an FBC and iron studies alongside HbA1c rather than reading it alone.

What a low result can indicate

A low HbA1c usually means normal glucose metabolism, but a result well below the reference range can reflect shortened red cell survival rather than low blood sugar.

Anything that shortens red cell lifespan gives glucose less time to attach and pushes HbA1c artificially down: haemolytic anaemia, recent significant blood loss, recent transfusion, pregnancy, advanced chronic kidney disease, and some haemoglobinopathies including thalassaemia trait — which is common in Australia.

In these situations HbA1c is unreliable and Australian guidance is to use alternatives such as fasting plasma glucose or an oral glucose tolerance test. Your GP decides which is appropriate.

A genuinely low HbA1c in someone taking glucose-lowering medicines can indicate frequent hypoglycaemia, which is a reason to review those medicines with the prescribing doctor.

Australian reference ranges and diagnostic thresholds

Australian laboratories report HbA1c in mmol/mol with the percentage equivalent, and apply the diagnostic threshold of 48 mmol/mol (6.5%) for diabetes on a laboratory-measured sample.

What affects your HbA1c result

HbA1c measures glucose bound to haemoglobin, so anything that changes how long your red cells live — iron deficiency, recent blood loss, transfusion, pregnancy, advanced kidney disease or a haemoglobin variant — changes the result independently of your actual blood sugar.

This is the part most people miss. HbA1c is not a direct glucose measurement; it is a measurement of how much glucose has stuck to haemoglobin over the lifespan of your circulating red cells, which averages around 120 days. Shorten that lifespan and there is less time for glucose to accumulate, so the result reads low. Lengthen it and the result reads high. Neither has anything to do with how well your metabolism is handling sugar.

Iron deficiency is the most common example in Australian practice, and it pushes the result the counter-intuitive way: untreated iron deficiency tends to raise HbA1c, and correcting it with iron can drop the number by several mmol/mol without any change to diet or activity. Because iron deficiency is common in menstruating women, endurance athletes and frequent blood donors, this is a live issue rather than a footnote — it is the main reason we suggest running iron studies and a full blood count alongside an HbA1c rather than after it.

In the other direction, anything that destroys or dilutes red cells early lowers HbA1c: haemolytic anaemia, recent significant blood loss, a transfusion in the preceding three months, and the increased red cell turnover of later pregnancy. Advanced chronic kidney disease and dialysis distort the result in ways that are hard to predict. Some haemoglobin variants — more common in people of African, Mediterranean, Middle Eastern and South-East Asian ancestry — interfere with certain assays outright; where one is present the laboratory should be told so an unaffected method is used.

There are also genuine metabolic influences that are not artefacts at all. Corticosteroids such as prednisolone raise glucose and, over weeks, HbA1c. Untreated obstructive sleep apnoea, significant weight change, a new exercise habit and shift work all move it, and the change appears gradually because the marker is an average, not a snapshot. That averaging also means a single heavy weekend will not show up, and equally that one strict week before the blood draw will not hide anything.

A practical consequence: because HbA1c reflects roughly the previous two to three months, repeating it sooner than about three months rarely tells you anything new. If you are tracking a deliberate change, test at the start and again at twelve weeks.

Who should consider an HbA1c test

HbA1c suits adults with any risk factor for type 2 diabetes, anyone tracking metabolic health, and people already diagnosed who are monitoring control.

HbA1c is not the right test for diagnosing diabetes in pregnancy, in children, or where type 1 diabetes is suspected — those need different testing arranged by a doctor, urgently in the case of suspected type 1.

• Adults aged 40 and over, or younger with a family history or higher-risk ancestry.
• Anyone with a previous high-risk HbA1c, or a history of gestational diabetes.
• People with high blood pressure, raised lipids, fatty liver or polycystic ovary syndrome.
• Anyone establishing a metabolic baseline alongside lipids, liver function and a full blood count.
• People with known diabetes monitoring control between GP reviews.

Which panel includes HbA1c

HbA1c is included in all four standard FORM Australia panels — Essential, Pro, Elite Protocol and Ultra — and can also be added to a custom panel you build yourself.

HbA1c is rarely worth ordering completely alone, because a single average-glucose number tells you little about why it sits where it does. In the FORM Australia panels it is grouped with the rest of the cardiometabolic markers: Essential pairs it with fasting glucose and the full lipid panel, while Pro, Elite Protocol and Ultra add fasting insulin, ApoB and Lp(a) — the markers that separate 'high glucose' from 'insulin resistance developing quietly for years'.

The other reason to test it in company is the interference problem described above. Iron deficiency distorts HbA1c, and every FORM Australia panel includes a full blood count, with ferritin and iron studies from Pro upwards, so a misleading result can be recognised as misleading rather than acted on.

• Australian blood test panels (Essential to Ultra) — All four panels include HbA1c, fasting glucose and a full lipid panel; from A$299 for 32 biomarkers.
• Build your own Australian panel — Pair HbA1c with fasting insulin, lipids and liver markers in one draw if you don't want a full tier.
• Full blood count — Included in every panel — the check that catches an anaemia distorting your HbA1c.
• Iron studies — Ferritin and transferrin saturation; untreated iron deficiency can push HbA1c up on its own.
• Thyroid function test — Thyroid disease commonly sits behind unexplained weight and energy changes attributed to blood sugar.

How testing works with FORM in Australia

You choose the test, we issue an Australian pathology request form, you walk in to an accredited collection centre at any time of day, and your result is returned in mmol/mol and % with a written explanation.

• No referral from your own GP is required. Privately requested pathology is arranged under a request from a registered medical practitioner working with our accredited lab partner.
• Collection is a walk-in at Laverty (Healius) pathology centres Australia-wide.
• No fasting and no timing requirement — HbA1c can be collected whenever suits you.
• Results typically report within one to two business days, in mmol/mol with the percentage equivalent.
• We recommend running a full blood count and iron studies alongside, because anaemia can distort HbA1c.
• FORM is a diagnostic testing service. We do not diagnose diabetes, prescribe or treat — any result at or above 42 mmol/mol should be taken to your GP.
• Australian ordering is currently pre-sale. Join the waitlist for launch notification.